UTSW Simmons Cancer Center

Official Twitter account for the Harold C. Simmons Comprehensive Cancer Center at @UTSWMedCenter. Retweets and links are not endorsements.

[UTSW Simmons Cancer Center @utswcancer]

@RTHeslin @ZachWhitham402 @MPettigrewMD @GilbertZMurimwa @MPorembka @PatricioPolanc0 @herbert_zeh @AdamYopp @SamWangMD @Alex_Kim_HIPEC @UTSW_Surgery

[UTSW Simmons Cancer Center @utswcancer]

In a new study published in @JAMAOnc, #UTSW researchers found that language barriers may contribute to treatment delays in early-onset colorectal cancer, with delayed treatment linked to worse survival, highlighting opportunities to improve equitable care.
https://t.co/S6pbEKtuYQ

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

Congrats to @andyzwang & all fellows inducted to the @AcadofInventors #NAI2026 tonight. Certainly recognizes a lifetime of achievement and innovation for betterment of all humans/society.
@UTSW_RadOnc @UTSWMedCenter @OncoAlert @CAHON_hemonc

[Alex C. Kim, MD, PhD @Alex_Kim_HIPEC]

Excited to share our new work in @JAMAOnc on early onset #colorectalcancer. https://t.co/1cdL8U5Xep

Using real-world data from last 20 years in Texas-one of the most diverse states in the US-we identified two key findings:

[UTSW Simmons Cancer Center @utswcancer]

Join us July 30–31 for “Cancer Care Essentials for Oncology APPs and the Multidisciplinary Team,” a hybrid CME conference featuring expert-led sessions, case discussions, and practical clinical insights.

Learn more and register: https://t.co/8q4Tq08SH1.

[Daniel Goyco Vera @DanielGoycoMed]

That’s a wrap on #ASCO2026 Great time presenting late infeftious complications of CAR-T for LBCL patients and catching up with old friends from residency @utswcancer

[UTSW Simmons Cancer Center @utswcancer]

“Scanxiety” is real. In a recent @dallasnews feature, Medical Director of Psycho-Oncology Laura Howe-Martin, Ph.D., shares insight into the anxiety many cancer patients experience around scans and waiting for results — and how emotional support can help. https://t.co/DNMyvt3bOy

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

Our group @CharlesJiangMD @andyzwang #AngelLu found a signal in real world data for PCSK9 inhibitors improving IO effect. OS difference w/out diff in cardio events. Pub’d concurrently today @JAMANetworkOpen. See you at posters!
@ASCO #ASCO26 @OncoAlert @urotoday @OncBrothers

[Charles Jiang MD, MPH @CharlesJiangMD]

We found a cholesterol drug linked to longer survival in cancer patients on ICI but CVD Benefit is not the reason OS HR: 0.69. Two year survival 62% vs 51%. Out today in @JAMANetworkOpen . Come see it: #asco26 Poster 447, Sat PM @TiansterZhang .https://t.co/gyCr7MfZ7v

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

@asco #ASCO26 — come for the science, stay for the people. Love our connections with friends near & far through the years, tied by common passion to improve outcomes for our patients w cancer.
@oncoalert @urotoday @utswcancer @dukegucancer

[UTSW Simmons Cancer Center @utswcancer]

A must-see session is coming up today at #ASCO26!

Don’t miss David Hsieh, M.D., as he presents early clinical results of a novel Wnt/β-catenin inhibitor in advanced liver cancer, followed by a panel Q&A.

View Dr. Hsieh’s presentation details: https://t.co/S0u0x4r7tW.

@ASCO

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

Thanks for having me present #GU bladder cancer highlights @ASCO #ASCO26 scientific committee!!
@OncoAlert @urotoday

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

Our @utswcancer GU group out in force showing our #CTC work in #bladdercancer! The GU posters are hopping!
@asco #ASCO26 @oncoalert @urotoday

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

Bright and early on #ASCO26 Sunday!
See you in D1 or online =)
@OncoAlert @urotoday @BladderCancerUS

[UTSW Simmons Cancer Center @utswcancer]

Another day of #ASCO26 is here!

Don’t miss @TiansterZhang this morning as she leads the 8 a.m. “Highlights of the Year” session showcasing the latest advances in transforming bladder cancer treatment.

View Dr. Zhang’s presentation details: https://t.co/S0u0x4r7tW.

@ASCO

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

Clinical science symposium — toward cures in #kidneycancer #bladdercancer!! Fantastic chairing by @QianJanieQin @utswcancer & @koshkin85 @UCSFCancer
@asco #asco26 @oncoalert @urotoday

[Arthi Sridhar @ASridharMD]

Thanks for amplifying! Come visit poster board 216 this afternoon if you are interested in learning about a bench to bedside clinical trial born from science from @utswcancer and @ucincinnati inhibiting fatty acid synthase in mKRAS NSCLC. Proud to represent @UTSWHemeOnc @UTSWMedCenter.

[UTSW Simmons Cancer Center @utswcancer]

#ASCO26 is here and we have a strong lineup of presentations on Saturday, May 30.

Catch @QianJanieQin, @AdamYopp, and @hmcarthur, as they lead expert sessions on bladder, kidney, liver, and breast cancer.

View their presentation details: https://t.co/S0u0x4r7tW.

@ASCO

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

Good morning Chicago! Kidney/bladder orals today Friday @asco #ASCO26!!
Looking forward to seeing the wins for our patients with cancer, networking, and considering new trials that will make a difference. Here for all of it!!
@oncoalert @utswcancer @urotoday

[UTSW Simmons Cancer Center @utswcancer]

Safe travels to those heading to the 2026 @ASCO Annual Meeting in Chicago! From posters to podiums, our experts will be sharing their latest research and clinical advancements all weekend long. See you there!

View all UTSW involvement at #ASCO26: https://t.co/S0u0x4r7tW.